Biomimetic Strategies To Treat Traumatic Brain Injury by Leveraging Fibrinogen

Ashley C. Brown, Erin Lavik, Sarah Stabenfeldt

Research output: Contribution to journalArticle

Abstract

There were over 27 million new cases of traumatic brain injuries (TBIs) in 2016 across the globe. TBIs are often part of complicated trauma scenarios and may not be diagnosed initially because the primary clinical focus is on stabilizing the patient. Interventions used to stabilize trauma patients may inadvertently impact the outcomes of TBIs. Recently, there has been a strong interest in the trauma community toward administrating fibrinogen-containing solutions intravenously to help stabilize trauma patients. While this interventional shift may benefit general trauma scenarios, fibrinogen is associated with potentially deleterious effects for TBIs. Here, we deconstruct what components of fibrinogen may be beneficial as well as potentially harmful following TBI and extrapolate this to biomimetic approaches to treat bleeding and trauma that may also lead to better outcomes following TBI.

Original languageEnglish (US)
Pages (from-to)1951-1956
Number of pages6
JournalBioconjugate chemistry
Volume30
Issue number7
DOIs
StatePublished - Jul 17 2019

Fingerprint

Biomimetics
Fibrinogen
Brain
Wounds and Injuries
Traumatic Brain Injury
Hemorrhage

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomedical Engineering
  • Pharmacology
  • Pharmaceutical Science
  • Organic Chemistry

Cite this

Biomimetic Strategies To Treat Traumatic Brain Injury by Leveraging Fibrinogen. / Brown, Ashley C.; Lavik, Erin; Stabenfeldt, Sarah.

In: Bioconjugate chemistry, Vol. 30, No. 7, 17.07.2019, p. 1951-1956.

Research output: Contribution to journalArticle

@article{fe61ba29161b4d548fef0df67f423951,
title = "Biomimetic Strategies To Treat Traumatic Brain Injury by Leveraging Fibrinogen",
abstract = "There were over 27 million new cases of traumatic brain injuries (TBIs) in 2016 across the globe. TBIs are often part of complicated trauma scenarios and may not be diagnosed initially because the primary clinical focus is on stabilizing the patient. Interventions used to stabilize trauma patients may inadvertently impact the outcomes of TBIs. Recently, there has been a strong interest in the trauma community toward administrating fibrinogen-containing solutions intravenously to help stabilize trauma patients. While this interventional shift may benefit general trauma scenarios, fibrinogen is associated with potentially deleterious effects for TBIs. Here, we deconstruct what components of fibrinogen may be beneficial as well as potentially harmful following TBI and extrapolate this to biomimetic approaches to treat bleeding and trauma that may also lead to better outcomes following TBI.",
author = "Brown, {Ashley C.} and Erin Lavik and Sarah Stabenfeldt",
year = "2019",
month = "7",
day = "17",
doi = "10.1021/acs.bioconjchem.9b00360",
language = "English (US)",
volume = "30",
pages = "1951--1956",
journal = "Bioconjugate Chemistry",
issn = "1043-1802",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Biomimetic Strategies To Treat Traumatic Brain Injury by Leveraging Fibrinogen

AU - Brown, Ashley C.

AU - Lavik, Erin

AU - Stabenfeldt, Sarah

PY - 2019/7/17

Y1 - 2019/7/17

N2 - There were over 27 million new cases of traumatic brain injuries (TBIs) in 2016 across the globe. TBIs are often part of complicated trauma scenarios and may not be diagnosed initially because the primary clinical focus is on stabilizing the patient. Interventions used to stabilize trauma patients may inadvertently impact the outcomes of TBIs. Recently, there has been a strong interest in the trauma community toward administrating fibrinogen-containing solutions intravenously to help stabilize trauma patients. While this interventional shift may benefit general trauma scenarios, fibrinogen is associated with potentially deleterious effects for TBIs. Here, we deconstruct what components of fibrinogen may be beneficial as well as potentially harmful following TBI and extrapolate this to biomimetic approaches to treat bleeding and trauma that may also lead to better outcomes following TBI.

AB - There were over 27 million new cases of traumatic brain injuries (TBIs) in 2016 across the globe. TBIs are often part of complicated trauma scenarios and may not be diagnosed initially because the primary clinical focus is on stabilizing the patient. Interventions used to stabilize trauma patients may inadvertently impact the outcomes of TBIs. Recently, there has been a strong interest in the trauma community toward administrating fibrinogen-containing solutions intravenously to help stabilize trauma patients. While this interventional shift may benefit general trauma scenarios, fibrinogen is associated with potentially deleterious effects for TBIs. Here, we deconstruct what components of fibrinogen may be beneficial as well as potentially harmful following TBI and extrapolate this to biomimetic approaches to treat bleeding and trauma that may also lead to better outcomes following TBI.

UR - http://www.scopus.com/inward/record.url?scp=85070025129&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070025129&partnerID=8YFLogxK

U2 - 10.1021/acs.bioconjchem.9b00360

DO - 10.1021/acs.bioconjchem.9b00360

M3 - Article

C2 - 31246419

AN - SCOPUS:85070025129

VL - 30

SP - 1951

EP - 1956

JO - Bioconjugate Chemistry

JF - Bioconjugate Chemistry

SN - 1043-1802

IS - 7

ER -